The Case for Greater Investment in VTE Research – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Ryan Coute et al, adding:
“National Institutes of Health Funding for Venous Thromboembolism Research.
Despite VTE causing approximately 100,000 annual US deaths, NIH funding per death remains critically disproportionate at 639 dollars for VTE compared to 2,765 dollars for heart disease and 2,724 dollars for stroke, highlighting a significant research investment gap that urgently needs to be addressed.”
Title: National Institutes of Health funding for venous thromboembolism research
Authors: Ryan A. Coute, Jake Toy, Kameshwari Soundararajan, Benjamin von Schweinitz, Patrick J. Siler, Ryan C. Godwin, Ryan L. Melvin
Read the Full Article on Journal of Thrombosis and Haemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 21, 2026, 00:58Anees Ur Rahman: Completing a Two-Week Clinical Rotation at Haemophilia Treatment Centre Rawalpindi
-
Oct 21, 2026, 00:56Caitlyn Mooney: Pulmonary Embolism in Athletes, Recognition and Return to Sport
-
Oct 21, 2026, 00:54Hani Karrar: Pleased to Share Our Review on Emicizumab in Hemophilia A Management
-
Oct 21, 2026, 00:53Akshay Sharma: HSCT Leads to Sustained Improvements in Sickle Cell Cardiomyopathy for Up to 3 Years
-
Oct 21, 2026, 00:51Prateek Meena: The F. A. T. R. N. Mnemonic for Recognizing TTP
-
Oct 20, 2026, 23:51Registration Is Open for WFH CCS 2027 – World Federation of Hemophilia
-
Oct 20, 2026, 23:44Edward Lee Carter: AF in Nursing Homes – When Stroke Risk Scores Tell Only Part of the Story
-
Oct 20, 2026, 22:59Building Effective Patient Advocacy Through Collaboration Between Patients and Clinicians – EHC
-
Oct 20, 2026, 21:22Intezar Mehdi: When Prolonged Bleeding May Indicate an Underlying Bleeding Disorder